News Industry News New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology August 20, 2015
News Industry News Jardiance® demonstrated cardiovascular (CV) risk reduction in people with type 2 diabetes at high risk for CV events August 20, 2015
News Daily News Un Nuevo Inhibidor Antisentido Reduce los Niveles Altos de Triglicéridos August 13, 2015
News Daily News BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival Yael L. Maxwell August 12, 2015
News Industry News Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions June 05, 2015
News Daily News Vorapaxar es Eficaz como Prevención Secundaria en Pacientes Diabéticos con Antecedentes de IM L.A. McKeown February 22, 2015
News Daily News Vorapaxar Effective for Secondary Prevention in Diabetic Patients With Prior MI L.A. McKeown February 22, 2015
News Daily News CREDO-Kyoto: Diabetic Patients With 3-Vessel or Left Main Disease Fare Better With CABG February 08, 2015
News Daily News Studies Explore Impact of Diabetes on Platelet Reactivity in Clopidogrel-Treated PCI Patients October 10, 2014
News Daily News PCI, Surgery Show Similar Long-term Mortality in Diabetic, Nondiabetic Patients L.A. McKeown August 15, 2012
News Daily News Meta-analysis: Early Invasive Strategy Best for Diabetic Patients with NSTE ACS July 03, 2012
News Daily News Better Clopidogrel Response Seen with Increased Smoking Levels Jason Kahn March 21, 2012
News Daily News HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics Jason Kahn July 18, 2011
News Daily News Study Compares Stents, Surgery in Diabetics with Multivessel Disease Caitlin E. Cox March 23, 2011
News Daily News Prasugrel Inhibits Platelet Function Better Than High-Dose Clopidogrel in Diabetics Jason Kahn January 26, 2011
News Industry News Leading health organizations collaborate with industry on new initiative to combat growing diabetes and cardiovascular disease threat